O'Shaughnessy Ventures Backs Bioengineer Developing Injectable Blood Vessels

O'Shaughnessy Ventures LLC (OSV) has awarded a fellowship to bioengineer Liam Aranda-Michel for his work on developing injectable blood vessels. The goal of the research is to create a therapy that can restore blood circulation through minimally invasive injection, potentially bypassing the need for traditional open surgery.

Aranda-Michel's project, supported by the O'Shaughnessy Fellowship, focuses on engineering artificial blood vessels. These vessels are intended to repair damaged or blocked arteries and veins, offering an alternative to conventional surgical procedures. This approach aims to reduce patient recovery times and surgical risks associated with vascular repair.

The development could have significant implications for treating cardiovascular diseases, a leading cause of death worldwide. OSV's support highlights a commitment to fostering innovation in medical science and advancing solutions for complex health challenges.

This investment by OSV positions Aranda-Michel's research at the forefront of biomaterials and regenerative medicine. The fellowship provides resources to further develop and potentially commercialize this novel therapeutic technology.